Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.020 Biomarker phenotype BEFREE We also demonstrated the potential value of adiponectin as the treatment target for different types of neurodegenerative and psychiatric disorders. 30864396 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.020 AlteredExpression phenotype BEFREE Cord blood adiponectin, TNF-α and IL-6 levels were not associated with child behavioral problems. 29324697 2018
CUI: C0702166
Disease: Acne
Acne
0.020 GeneticVariation disease BEFREE In this study, we aimed to evaluate adipokines such as leptin (L), adiponectin (A), ghrelin and A levels, and A/L rates that indicate insulin resistance in nonobese patients with severe acne vulgaris. 26860691 2017
CUI: C0702166
Disease: Acne
Acne
0.020 Biomarker disease BEFREE Remarkably, this OGTT-induced adiponectin increment in acne patients was diminished after isotretinoin treatment. 29190629 2017
CUI: C0001144
Disease: Acne Vulgaris
Acne Vulgaris
0.020 Biomarker disease BEFREE Remarkably, this OGTT-induced adiponectin increment in acne patients was diminished after isotretinoin treatment. 29190629 2017
CUI: C0001144
Disease: Acne Vulgaris
Acne Vulgaris
0.020 GeneticVariation disease BEFREE In this study, we aimed to evaluate adipokines such as leptin (L), adiponectin (A), ghrelin and A levels, and A/L rates that indicate insulin resistance in nonobese patients with severe acne vulgaris. 26860691 2017
CUI: C2936664
Disease: Acquired Hypogammaglobulinemia
Acquired Hypogammaglobulinemia
0.020 Biomarker disease BEFREE Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy. 31827477 2019
CUI: C2936664
Disease: Acquired Hypogammaglobulinemia
Acquired Hypogammaglobulinemia
0.020 Biomarker disease BEFREE Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy. 28824624 2017
CUI: C0333233
Disease: Active Hyperemia
Active Hyperemia
0.300 Biomarker phenotype CTD_human Association of hypoadiponectinemia with impaired vasoreactivity. 12860835 2003
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 Biomarker disease BEFREE In contrast to prior observational data for incident CHD, adiponectin is prospectively associated with MACEs and death in patients with type 2 diabetes and ACS, and an increase in adiponectin from baseline is directly related to death. 29903845 2018
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 GeneticVariation disease BEFREE According to the cut-off point identified by ROC curve, adiponectin values≤2.56μg/mL were correlated with a higher risk of ACS occurrence at 12months' follow-up (p-value for Log Rank test=0.0003). 29305337 2018
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 Biomarker disease BEFREE We analysed baseline adiponectin concentration and CV outcomes in 5213 patients with type 2 diabetes enrolled in the EXAMINE trial of alogliptin vs placebo 15 to 90 days (median 45 days) after ACS.Event rates at 18 months are reported. 28195387 2017
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.040 GeneticVariation disease BEFREE The present study suggests that only T45G single-nucleotide polymorphism in the adiponectin gene is associated with higher odds for ACS events and has an effect on serum adiponectin levels among Arab populations. 22887729 2013
CUI: C2118460
Disease: Acute colitis
Acute colitis
0.010 Biomarker disease BEFREE Adiponectin confers protection from acute colitis and restricts a B cell immune response. 28258220 2017
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.040 AlteredExpression disease BEFREE Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis. 29305337 2018
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.040 Biomarker disease BEFREE Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. 28195387 2017
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.040 AlteredExpression disease BEFREE Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. 22887729 2013
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.040 Biomarker disease BEFREE We investigated relationships of adiponectin and FFA and major adverse cardiovascular events (MACEs) and death in patients with acute coronary syndrome (ACS) and type 2 diabetes using data from the AleCardio (Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus) trial, which compared the PPAR-α/γ agonist aleglitazar with placebo. 29903845 2018
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.020 Biomarker disease BEFREE We have discussed the established biomarkers for AHF including cardiac troponins and natriuretic peptides and emerging biomarkers including adiponectin, mi-RNA, sST2, Gal-3, MR-proADM, OPG, CT-proAVP and H-FABP for the purposes of making diagnosis, their use as a guide of therapy or for determination of prognosis. 31580155 2019
CUI: C0264714
Disease: Acute heart failure
Acute heart failure
0.020 Biomarker disease BEFREE The correlation between the two biomarkers and the renal function was analyzed by Spearman's correlation, while the diagnostic efficiency of ADPN and NT-proBNP was evaluated in AHF patients with and without renal insufficiency. 30210613 2018
CUI: C0267797
Disease: Acute hepatitis
Acute hepatitis
0.010 Biomarker disease BEFREE These data indicated that LPS/D-Gal-induced acute hepatitis was effectively attenuated by the adiponectin receptor agonist AdipoRon, implying that AdipoRon might become a new reagent for treatment of acute hepatitis. 31651516 2019
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.030 Biomarker disease BEFREE We hypothesised that adiponectin may be inversely associated with acute myeloblastic leukaemia (AML), but not with acute lymphoblastic leukaemia of B (ALL-B) or T (ALL-T) cell origin in children. 16404369 2006
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.030 AlteredExpression disease BEFREE The majority of the studies indicated that leptin levels are increased and adiponectin levels are decreased in ALL children at diagnosis, as well as in ALL survivors. 30696312 2019
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.030 AlteredExpression disease BEFREE No significant differences in hip circumference, leptin levels, adiponectin levels, and body weight were observed between the 2 groups.This preliminary study suggests that short-term supplementation of high-proportion MCT nutrition preparation may help reduce the centripetal distribution of adipose induced by the application of glucocorticoids in children with ALL. 31415396 2019
CUI: C0023479
Disease: Acute myelomonocytic leukemia
Acute myelomonocytic leukemia
0.010 Biomarker disease BEFREE At least one mechanism of the growth inhibition is induction of apoptosis because treatment of acute myelomonocytic leukemia lines with adiponectin induced the appearance of subdiploid peaks and oligonucleosomal DNA fragmentation. 10961870 2000